Early Application of Continuous Positive Airway Pressure in Coronavirus Patients at Risk of Obstructive Sleep Apnea
Covid19, Obstructive Sleep Apnea, CPAP Ventilation
About this trial
This is an interventional supportive care trial for Covid19 focused on measuring ( Coronavirus disease 2019), Coronavirus infections, sleep breathing disorder, obstructive sleep apnea
Eligibility Criteria
Inclusion Criteria: patients age above 18 years, diagnosed with moderate to severe (Coronavirus disease 2019) and at risk of Obstructive Sleep Apnea as well as confirmed nasopharyngeal swab positive for (Severe acute respiratory syndrome coronavirus 2) ( by (polymerase chain reaction). Exclusion Criteria: patients were excluded from the study if their age <18 years, hypercapnic, unstable cardiorespiratory (shock) status or respiratory arrest and if there are any contraindications for ( Continuous Positive Airway Pressure (CPAP) mask use
Sites / Locations
- Mansoura University
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Continuous Positive Airway Pressure (CPAP) group in (Coronavirus disease 2019) patients
Non-CPAP group
receive medical treatment plus oxygen therapy according to recommendation of protocol of the Egyptian Ministry of Health 2020 and using Continuous Positive Airway Pressure (CPAP)
Non-CPAP group will receive medical treatment plus oxygen therapy according to recommendation of protocol of the Egyptian Ministry of Health 2020